I think that at that time the planned range of use for the NovoSorb tech was more limited than it is now.
Alone, the Indications for use of BTM and MTX have expanded greatly since then and, as with the cell therapy silo, this has been driven by users not the company.
In another 5 years time this will be a much bigger company but with a lot more growth to look forward to.
PNV Price at posting:
$1.21 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)